AKT1 and neoplasm: MIR4435-2HG has been extensively studied for its ability to affect tumor development through multiple pathways, including the Wnt/β-catenin, DM2/p53, PI3K/AKT, and MAPK/ERK signaling pathway (Zhong et al. 2022).